Treatment of advanced basal cell carcinoma with hedgehog pathway inhibitors: A multidisciplinary expert meeting

Vincenzo De Giorgi, Federica Scarfì, Luciana Trane, Flavia Silvestri, Federico Venturi, Biancamaria Zuccaro, Giuseppe Spinelli, Silvia Scoccianti, Francesco De Rosa, Emi Dika, Caterina Longo

Research output: Contribution to journalArticlepeer-review

Abstract

Despite recent progress and the publishing of several clinical guidelines on the management of advanced basal cell carcinoma, there is still no comprehensive set of clinical guidelines addressing the complexity inherent to the use of Hedgehog pathway inhibitors in the treatment of advanced basal cell carcinoma in real-world clinical practice. To develop practical and valuable tools that help specialists improve the clinical management of these patients, we sought the opinion of expert physicians with extensive knowledge and experience in the treatment of advanced basal cell carcinoma.

Original languageEnglish
Article number5706
JournalCancers
Volume13
Issue number22
DOIs
Publication statusPublished - Nov 1 2021

Keywords

  • Cemiplimab
  • Skin cancer
  • Sonidegib
  • Therapy
  • Vismodegib

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Fingerprint

Dive into the research topics of 'Treatment of advanced basal cell carcinoma with hedgehog pathway inhibitors: A multidisciplinary expert meeting'. Together they form a unique fingerprint.

Cite this